Xiaoming Li

机构：Fujian Medical University, Harbin Medical University, Third Affiliated Hospital of Harbin Medical University · ORCID：0009-0007-3700-8558

发表论文 94 篇 · 总被引 1672 次 · h-index 25

代表论文

• NAFLD‐related gene polymorphisms and all‐cause and cause‐specific mortality in an Asian population: the Shanghai Changfeng Study (2022 · Alimentary Pharmacology & Therapeutics · 被引 37)
• Osteocalcin and Non-Alcoholic Fatty Liver Disease: Lessons From Two Population-Based Cohorts and Animal Models (2020 · Journal of Bone and Mineral Research · 被引 37)
• Stress triggers irritable bowel syndrome with diarrhea through a spermidine-mediated decline in type I interferon (2024 · Cell Metabolism · 被引 32)
• Presence of sarcopenia identifies a special group of lean NAFLD in middle-aged and older people (2022 · Hepatology International · 被引 29)
• Platelet‐Derived Growth Factor Nanocapsules with Tunable Controlled Release for Chronic Wound Healing (2024 · Small · 被引 22)
• Single-cell RNA sequencing reveals a novel inhibitory effect of ApoA4 on NAFL mediated by liver-specific subsets of myeloid cells (2022 · Frontiers in Immunology · 被引 18)